Edition:
United States

Beijing Leadman Biochemistry Co Ltd (300289.SZ)

300289.SZ on Shenzhen Stock Exchange

15.05CNY
--
Change (% chg)

-- (--)
Prev Close
¥15.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,807,801
52-wk High
¥17.53
52-wk Low
¥10.31

Latest Key Developments (Source: Significant Developments)

Beijing Leadman Biochemistry signs cooperation contract
Monday, 17 Jul 2017 03:44am EDT 

July 17(Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ> ::* Says it signs cooperation contract for study on the suitability in Vitros5600.  Full Article

Beijing Leadman Biochemistry sees FY 2017 H1 net profit to increase by 10 pct to 40 pct
Friday, 14 Jul 2017 02:56am EDT 

July 14(Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ> ::* Says net profit for FY 2017 H1 to increase by 10 percent to 40 percent, or to be 39 million yuan to 49.6 million yuan, compared to net profit of FY 2016 H1 (35.4 million yuan).  Full Article

Beijing Leadman Biochemistry says dividend payment date
Thursday, 8 Jun 2017 02:00am EDT 

June 8 (Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ>:* Says it pay a cash dividend of 0.1 yuan per 10 shares (before tax) for 2016 to shareholders of record on June 14.* The company's shares will be traded ex-right and ex-dividend on June 15 and the dividend will be paid on June 15.  Full Article

Beijing Leadman Biochemistry sets up Fujian medical devices JV with individual
Wednesday, 17 May 2017 02:28am EDT 

May 17 (Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ>:* Says it completed establishment of a medical devices JV in Fujian with an individual .  Full Article

Beijing Leadman Biochemistry receives patent
Friday, 12 May 2017 02:52am EDT 

May 12 (Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ> ::* Says it received patent(No. ZL 2013 1 0522632.X), for level detecting and sensing devices used on fully automatic biochemistry analyzer.* Patent is valid for 20 years .  Full Article

Beijing Leadman Biochemistry to buy 23 pct stake in pharma device subsidiary for 92,000 yuan
Thursday, 11 May 2017 03:32am EDT 

May 11 (Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ> ::* Says it will buy additional 23 percent stake in a Beijing-based pharma device company, for 92,000 yuan .* Its stake in target company will be raised to 100 percent after transaction .  Full Article

Beijing Leadman Biochemistry to pay cash div 0.1 yuan per 10 shares for FY 2016
Tuesday, 25 Apr 2017 11:57pm EDT 

April 26 (Reuters) - Beijing Leadman Biochemistry Co Ltd <300289.SZ> ::* Says it plans to pay cash div 0.1 yuan per 10 shares for FY 2016.  Full Article

Beijing Leadman Biochemistry Co Ltd sees Q1 FY 2017 net profit down 10 pct to up 10 pct
Monday, 10 Apr 2017 02:38am EDT 

Beijing Leadman Biochemistry Co Ltd <300289.SZ> : Sees Q1 FY 2017 net profit to decrease by 10 percent to increase by 10 percent, or to be 16.2 million yuan to 19.8 million yuan . Says Q1 FY 2016 net profit was 18 million yuan .The reason for the forecast is strengthened the management of customer credit account, reduced bad debts risk and decreased income.  Full Article

Beijing Leadman Biochemistry plans two medical devices JVs with partners
Friday, 31 Mar 2017 10:22am EDT 

Beijing Leadman Biochemistry Co Ltd <300289.SZ> : Says co plans to invest 5.1 million yuan to set up a medical devices JV in Hubei with partner, and to hold a 51 percent stake in it .Says co plans to invest 2.6 million yuan to set up a medical devices JV in Fujian with partner, and to hold a 51 percent stake in it.  Full Article

Beijing Leadman Biochemistry sees FY 2016 net profit down 50 pct to 70 pct
Thursday, 26 Jan 2017 10:08am EST 

Beijing Leadman Biochemistry Co Ltd <300289.SZ> : Sees FY 2016 net profit to decrease by 50 percent to 70 percent, or to be 47.2 million yuan to 78.6 million yuan . Says FY 2015 net profit was 157.2 million yuan .The main reason is increased sales expense on promotion.  Full Article

BRIEF-Beijing Leadman Biochemistry signs cooperation contract

* Says it signs cooperation contract for study on the suitability in Vitros5600